decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
National_Coverage_Determinations_Manual / ALPHA
Subscribe or sign in to view the full article.
Article Overview
This article is a brief National Coverage Determinations Manual entry focused on alpha-fetoprotein and its role in oncology-related monitoring and diagnosis. It is intended for coding and billing professionals, compliance staff, and clinicians who need to understand the coverage topic, the clinical settings discussed, and the applicable Medicare policy context.
Why This Topic Matters
It helps readers determine whether the coverage guidance for this laboratory-related oncology topic is relevant to their documentation and billing workflow.
What You Will Learn
- The clinical context addressed by the coverage entry
- The general types of malignancy-related indications discussed
- The Medicare policy source and revision context for the topic
- Who may need to review this guidance for coding or billing relevance
Who Should Read This
- Medical coders
- Billing specialists
- Compliance professionals
- Oncology clinicians
- Revenue cycle staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com